These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8946783)

  • 41. Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitation.
    Krajewska M; Rosenthal RE; Mikolajczyk J; Stennicke HR; Wiesenthal T; Mai J; Naito M; Salvesen GS; Reed JC; Fiskum G; Krajewski S
    Exp Neurol; 2004 Oct; 189(2):261-79. PubMed ID: 15380478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats.
    Tsubokawa T; Solaroglu I; Yatsushige H; Cahill J; Yata K; Zhang JH
    Stroke; 2006 Jul; 37(7):1888-94. PubMed ID: 16763180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of calpain in myonephropathic metabolic syndrome (MNMS).
    Tsuji Y; Kambayashi J; Shiba E; Sakon M; Kawasaki T; Mori T
    Eur J Vasc Surg; 1994 Jul; 8(4):482-8. PubMed ID: 8088401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The calcium-dependent protease calpain in neuronal remodeling and neurodegeneration.
    Metwally E; Zhao G; Zhang YQ
    Trends Neurosci; 2021 Sep; 44(9):741-752. PubMed ID: 34417060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of calcium-activated protease calpain in experimental retinal pathology.
    Azuma M; Shearer TR
    Surv Ophthalmol; 2008; 53(2):150-63. PubMed ID: 18348880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A possible therapeutic potential of quercetin through inhibition of μ-calpain in hypoxia induced neuronal injury: a molecular dynamics simulation study.
    Pandey AK; Shukla SC; Bhattacharya P; Patnaik R
    Neural Regen Res; 2016 Aug; 11(8):1247-53. PubMed ID: 27651771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases.
    Khan H; Garg N; Singh TG; Kaur A; Thapa K
    Neurochem Res; 2022 May; 47(5):1125-1149. PubMed ID: 34982393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting individual calpain isoforms for neuroprotection.
    Geddes JW; Saatman KE
    Exp Neurol; 2010 Nov; 226(1):6-7. PubMed ID: 20682310
    [No Abstract]   [Full Text] [Related]  

  • 49. Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?
    Baudry M
    Curr Neuropharmacol; 2019; 17(9):823-829. PubMed ID: 30819083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcium-activated neutral protease (calpain) system: structure, function, and regulation.
    Croall DE; DeMartino GN
    Physiol Rev; 1991 Jul; 71(3):813-47. PubMed ID: 2057527
    [No Abstract]   [Full Text] [Related]  

  • 51. Contribution of calcium-activated neutral protease to the degradation process of ischemic heart.
    Toyo-oka T; Morita M; Shin WS; Okaimatsuo Y; Sugimoto T
    Jpn Circ J; 1991 Nov; 55(11):1124-6. PubMed ID: 1749070
    [No Abstract]   [Full Text] [Related]  

  • 52. Calcium-mediated proximal tubular injury-what is the role of cysteine proteases?
    Edelstein CL
    Nephrol Dial Transplant; 2000 Feb; 15(2):141-4. PubMed ID: 10648654
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanisms underlying the neuronal response to ischemic injury. Calcium-activated proteolysis of neurofilaments.
    Schlaepfer WW; Zimmerman UJ
    Prog Brain Res; 1985; 63():185-96. PubMed ID: 3915124
    [No Abstract]   [Full Text] [Related]  

  • 54. Calpain as a novel target for treating acute neurodegenerative disorders.
    Bartus RT; Elliott PJ; Hayward NJ; Dean RL; Harbeson S; Straub JA; Li Z; Powers JC
    Neurol Res; 1995 Aug; 17(4):249-58. PubMed ID: 7477738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia.
    Hong SC; Goto Y; Lanzino G; Soleau S; Kassell NF; Lee KS
    Stroke; 1994 Mar; 25(3):663-9. PubMed ID: 8128523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study advancement of calpain and apoptosis following cerebral ischemia].
    Liu J; Xu J; Wang G; Yang M; Guo L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1150-3. PubMed ID: 19947509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration.
    Bartus RT; Hayward NJ; Elliott PJ; Sawyer SD; Baker KL; Dean RL; Akiyama A; Straub JA; Harbeson SL; Li Z
    Stroke; 1994 Nov; 25(11):2265-70. PubMed ID: 7974554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calpain as proposed target for neuroprotective treatment of brain ischemia.
    Zalewska T
    Folia Neuropathol; 1996; 34(3):121-7. PubMed ID: 8946783
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.